Hypophosphatasia

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

6 events
Sep 2025A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALE1 in Healthy Adults and Adults With Hypophosphatasia in Order to Identify Suitable Doses of ALE1

Alesta Therapeutics — PHASE1, PHASE2

TrialRECRUITING
May 2024Phase 3 Study of ALXN1850 in Treatment-Naïve Pediatric Participants With HPP

Alexion Pharmaceuticals, Inc. — PHASE3

TrialACTIVE NOT RECRUITING
Apr 2024Phase 3 Study of ALXN1850 in Pediatric Participants With HPP Previously Treated With Asfotase Alfa

Alexion Pharmaceuticals, Inc. — PHASE3

TrialACTIVE NOT RECRUITING
Aug 2022A Prospective Sub-Study of the Global Hypophosphatasia Registry

Alexion Pharmaceuticals, Inc.

TrialRECRUITING
Aug 2021United States Hypophosphatasia Molecular Research Center

Children's Mercy Hospital Kansas City

TrialRECRUITING
Jan 2015Registry of Patients With Hypophosphatasia

Alexion Pharmaceuticals, Inc.

TrialENROLLING BY INVITATION

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Hypophosphatasia.
Check the disease page for updates →

Clinical Trial Landscape

6 active trials
2Phase 3
3Unknown
1PHASE1, PHASE2
6Total recruiting
Search clinical trials for Hypophosphatasia

Recent News & Research

No recent news articles indexed yet for Hypophosphatasia.
Search PubMed for Hypophosphatasia

Browse all Hypophosphatasia news →

Specialist Network

Top 6 by expertise

View all Hypophosphatasia specialists →

Quick Actions